Cereport® (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone

Neuro-Oncology

Volumn 1, Issue 4, 1999, Pages 268-274

  Dean, Reginald L ^a   Emerich, Dwaine F ^a   Hasler, Brant P ^a   Bartus, Raymond T ^a  

^a ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; CARBOPLATIN; DEXAMETHASONE; DRUG DERIVATIVE; LOBRADIMIL;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BODY WEIGHT; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CHEMICAL PHENOMENA; DRUG ADMINISTRATION; DRUG EFFECT; DRUG POTENTIATION; FISCHER 344 RAT; GLIOMA; MALE; METABOLISM; ORGAN SIZE; PERMEABILITY; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BODY WEIGHT; BRADYKININ; BRAIN NEOPLASMS; CARBOPLATIN; DEPRESSION, CHEMICAL; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; GLIOMA; MALE; NEOPLASM TRANSPLANTATION; ORGAN SIZE; PERMEABILITY; RATS; RATS, INBRED F344; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; TUMOR CELLS, CULTURED;

EID: 0033206884     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1522851799000125     Document Type: Article

References (55)

1. Bartus, R.T. (1999) The blood-brain barrier as a target for pharmacological modulation. Curr. Opin. Drug Discov. Dev. 2, 152-167.
2. Bartus, R.T., Elliott, P.J., Dean, R.L., Hayward, N.J., Nagle, T.L., Huff, M.R., Snodgrass, P.A., and Blunt, D.G. (1996a) Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp. Neurol. 142, 14-28.
3. Bartus, R.T., Elliott, P., Hayward, N., Dean, R., McEwen, E.L., and Fisher, S.K. (1996b) Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology 33, 270-278.
4. Black, K.L. (1995) Biochemical opening of the blood-brain barrier. Adv. Drug Del. Rev. 15, 37-52.
5. Black, K.L., Cloughesy, T., Huang, S.C., Gobin, Y.P., Zhou, Y., Grous, J., Nelson, G., Farahani, K., Hoh, C.K., and Phelps, M. (1997) Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J. Neurosurg. 86, 603-609.
6. Cloughesy, T.F., Black, K.L., Gobin, Y.P., Farahani, K., Nelson, G., Villablanca, P., Kabbinavar, F., Vinuela, F., and Wortel, C.H. (1999) Intra-arterial Cereport (RMP-7) and carboplatin: A dose escalation study for recurrent malignant gliomas. Neurosurgery 44, 270-278.
7. Dean, R.L., Elliott, P.J., Nagle, T., Hayward, N., Merchant, R., and Bartus, R.T. (1996) RMP-7 increases uptake of carboplatin into rat gliomas: Comparison of three cell lines. Proc. Am. Assoc. Cancer Res. 37, 303. (Abstract)
8. Doctrow, S.R., Abelleira, S.M., Curry, L.A., Heller-Harrison, R., Kozarich, J.W., Malfroy, B., McCarroll, L.A., Morgan, K.G., Morrow, A.R., Musso, G.F., Smart, J.L., Straub, J.A., and Turnbull, B. (1994) The bradykinin analog RMP-7 increases extracellular free calcium levels in rat brain microvascular endothelial cells. J. Pharmacol. Exp. Ther. 271, 229-237.
9. Elliott, P.J., Hayward, N.J., Dean, R.L., Blunt, D.G., and Bartus, R.T. (1996a) Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. Cancer Res. 56, 3998-4005.
10. Elliott, P.J., Hayward, N.J., Huff, M.R., Nagle, T.L., Black, K.L., and Bartus, R.T. (1996b) Unlocking the blood-brain barrier: A role for RMP-7 in brain tumor therapy. Exp. Neurol. 141, 214-224.
11. Ford, J.M., Miles, K.A., Hayball, M.P., Bearcroft, P.W., Bleehen, N.M., and Osborn, C.S. (1996) A simplified technique for measurement of blood-brain barrier permeability using CT: Preliminary results of the effect of RMP-7. In: Faulkner, K., Carey, B., Crellin, A., and Harrison, R.M. (Eds.) Quantitative Imaging in Oncology. London: British Institute of Radiology. pp. 126-155.
12. French, L.A., and Galicich, J.H. (1964) The use of steroids for control of cerebral edema. Clin. Neurosurg. 10, 212-223.
13. Glaser, A.W., Buxton, N., and Walker, D. (1997) Corticosteroids in the management of central nervous system tumors. Arch. Dis. Child. 76, 76-78.
14. Gregor, A., Lind, M., and Osborn, C. (1997) Intravenous RMP-7 and carboplatin: Efficacy of a new treatment for recurrent malignant glioma. Eur. J. Cancer 53 (Suppl. 8), S17. (Abstract)
15. Groothius, D.R., Fischer, J.M., Lapin, G., Bigner, D.D., and Vick, N.A. (1982) Permeability of different experimental brain tumor models to horseradish peroxidase. J. Neuropathol. Exp. Neurol. 41, 164-185.
16. Guerin, C., Wolff, J.E., Laterra, J., Drewes, L.R., Brem, H., and Goldstein, G.W. (1992) Vascular differentiation and glucose transporter expression in rat gliomas: Effects of steroids. Ann. Neurol. 31, 481-487.
17. Gutin, P.H. (1977) Corticosteroid therapy in patients with brain tumors. J. Natl. Cancer Inst. Monogr. 46, 151-156.
18. Hatam, A., Bergstrôm, M., Yu, Z.Y., Granholm, L., and Berggren, B.M. (1983) Effect of dexamethasone treatment on volume and contrast enhancement of intracranial neoplasms. J. Comput. Assist. Tomogr. 7, 295-300.
19. Inamura, T., and Black, K.L. (1994) Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J. Cereb. Blood Flow. Metab. 14, 862-870.
20. Inamura, T., Nomura, T., Bartus, R.T., and Black, K.L. (1994) Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J. Neurosurg. 81, 752-758.
21. Jarden, J.O., Dhawan, V., Moeller, J., Strother, S.C., and Rottenberg, D.A. (1989) The time course of steroid action or blood-to-brain and blood-to-tumor transport of 82Rb: A positron emission tomographic study. Ann. Neurol. 25, 239-245.
22. Koehler, P.J. (1995) Use of corticosteroids in neuro-oncology. Anticancer Drugs 6, 19-33.
23. Levin, V.A., Freeman-Dove, M., and Landahl, H.D. (1975) Permeability characteristics of brain adjacent to tumors in rats. Arch. Neurol. 32, 785-791.
24. Lieberman, A., Le Brun, Y., Glass, P., Goodgold, A., Lux, W., Wise, A., and Ransohoff, J. (1977) Use of high dose corticosteroids in patients with inoperable brain tumors. J. Neurol. Neurosurg. Psychiat. 40, 678-682.
25. Long, D.M. (1970) Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J. Neurosurg. 32, 127-144.
26. Luthert, P.J., Greenwood, J., Lantos, P.L., and Pratt, O.E. (1986) The effect of dexamethasone on vascular permeability of experimental brain tumors. Acta Neuropathol. (Berlin) 69, 288-294.
27. Matsukado, K., Inamura, T., Nakano, S., Fukui, M., Bartus, R.T., and Black, K.L. (1996) Enhanced tumor uptake of carboplatin and survival in gliomabearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39, 125-134.
28. Matsukado, K., Nakano, S., Bartus, R.T., and Black, K.L. (1997) Steroids decrease uptake of carboplatin in rat gliomas-uptake improved by intracarotid infusion of bradykinin analog, RMP-7. J. Neurooncol. 34, 131-138.
29. Matsukado, K., Sugita, M., and Black, K.L. (1998) Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas. Brain Res. 792, 10-15.
30. Molnar, P., Lapin, G.D., and Groothius, D.R. (1995) The effects of dexamethasone on experimental brain tumors: 1. Transcapillary transport and blood flow in RG-2 rat gliomas. J. Neurooncol. 25, 19-28.
31. Nakagawa, H., Groothius, D.R., Owens, E.S., Fenstermacher, J.D., Patlak, C.S., and Blasberg, R.G. (1987) Dexamethasone effects on [125-1] albumin distribution in experimental RG-2 gliomas and adjacent brain. J. Cereb. Blood Flow Metab. 7, 687-701.
32. Nelson, D.F., McDonald, J.V., Lapham, L.W., Qazi, R., and Rubin, P. (1993) Central Nervous System Tumors. In McDonald, J., Qazi, R., and Rubin, P. (Eds.), Clinical Oncology: A Multidisciplinary Approach for Physicians and Students. Seventh edition. Philadelphia: W.B. Saunders Co. pp. 617-644.
33. Neuwelt, E.A., and Rapoport, S.I. (1984) Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed. Proc. 43, 214-219.
34. Neuwelt, E.A., Barnett, P.A., Bigner, D.D., and Frenkel, E.P. (1982) Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: The factor of the blood-brain barrier. Proc. Natl. Acad. Sci. U.S.A. 79, 4420-4423.
35. Neuwelt, E.A., Hill, S.A., and Frenkel, E.P. (1984) Osmotic blood-brain barrier modification and combination chemotherapy: Concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery 15, 362-366.
36. Neuwelt, E.A., Barnett, P.A., McCormick, C.I., Frenkel, E.P., and Minna, J.D. (1985) Osmotic blood-brain barrier modification: Monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neurosurgery 17, 419-423.
37. Neuwelt, E.A., Horaczek, A., and Pagel, M.A. (1990) The effect of steroids on gentamicin delivery to brain after blood-brain barrier disruption. J. Neurosurg. 72, 123-126.
38. Neuwelt, E.A., Barnett, P.A., Ramsey, F.L., Hellstrom, I., Hellstrom, K.E., and McCormick, C.I. (1993) Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts. Neurosurgery 33, 478-484.
39. Nomura, T., Inamura, T., and Black, K.L. (1994) Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res. 659, 62-66.
40. Pellegrino, L.J., Pellegrino, A.S., and Cushman, A.J. (1986) A Stereotaxic Atlas of the Rat Brain. Third edition. New York: Plenum Press.
41. Posner, J. (1992) Management of brain metastases. Rev. Neurol. (Paris) 148, 477-487.
42. Preston-Martin, S. (1999) Epidemiology. In Berger, M., and Wilson, C. (Eds.), The Gliomas. Philadelphia: W.B. Saunders. pp. 2-11.
43. Reichman, H.R., Farrell, C.L., and Del Maestro, R.F. (1986) Effects of steroids and non-steroid anti-inflammatory agents on vascular permeability in a ray glioma model. J. Neurosurg. 65, 233-237.
44. Renaudin, J., Fewer, D., Wilson, C.B., Boldrey, E.B., Calogero, J., and Enot, K.J. (1973) Dose dependency of Decadron in patients with partially excised brain tumors. J. Neurosurg. 39, 302-305.
45. Shapiro, W.R., Hiesiger, E.M., Cooney, G.A., Basler, G.A., Lipschutz, L.E., and Posner, J.B. (1990) Temporal effects of dexamethasone on blood-to-brain and blood-to-tumor transport of 14-C-alpha-aminoisobutyric acid in rat C6 glioma. J. Neurooncol. 8, 197-204.
46. Shibata, S. (1989) Ultrastructure of capillary walls in human brain tumors. Acta. Neuropathol. 78, 561-571.
47. Straathof, C.S.M., van den Bent, M.J., Ma, J., Schmitz, P.I.M., Kros, J.M., Stoter, G., Vecht, C.J., and Schellens, J.H.M. (1998) The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor. J. Neurooncol. 37, 1-8.
48. Straub, J.A., Akiyama, A., and Parmar, P. (1994) In vitro plasma metabolism of RMP-7. Pharmaceut. Res. 11, 1673-1676.
49. Tjuvajev, J., Uehara, H., Desai, R., Beattie, B., Marei, C., Zhou, Y., Kreerk, M., Koutcher, J., and Blasberg, R. (1996) Corticotropin-releasing factor decreases vasogenic brain edema. Cancer Res. 56, 1352-1360.
50. Tonolo, G., Fraser, R., Connell, J.M., and Kenyon, C.J. (1988) Chronic low-dose infusions of dexamethasone in rats: Effects on blood pressure, body weight and plasma atrial natriuretic peptide. J. Hypertens. 6, 25-31.
51. Vecht, C.J., and Verbiest, H.B.C. (1995) Use of glucocorticoids in neuro-oncology. In Wiley, R.G. (Ed.), Neurological Complications of Cancer. New York: Marcel Dekker. pp. 199-218.
52. Wolff, J., Guerin, C., Laterra, J., Bressler, J., Indurti, R.R., Brem, H., and Goldstein, G.W. (1993) Dexamethasone reduces vasular density and plasminogen activator activity in 9L rat brain tumors. Brain Res. 604, 79-85.
53. Yamada, K., Ushio, Y., Hayakawa, T., Arita, N., Yamada, N., and Mogami, H. (1983) Effects of methylprednisolone on peritumoral brain edema: A quantitative autoradiographic study. J. Neurosurg. 59, 612-619.
54. Yeung, W.T.I., Lee, T.Y., Del Maestro, R.F., Kozak, R., Bennett, J., and Brown, T. (1993) Effects of steroids on iopamidol blood-brain transfer constant and plasma volume in brain tumors measured with X-ray computed tomography. J. Neurooncol. 18, 53-60.
55. Zivlan, Y.Z., LeFauconnier, J.M., Bernard, G., and Bourre, J.M. (1988) Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier. J. Neurochem. 51, 1338-1342.